Actient Pharmaceuticals LLC
11
James L. Garrity Jr.
08/16/2022
06/25/2024
Yes
v
| MEGANY, MEGA, JtAdm, CLMAGT |
Assigned to: Judge James L. Garrity Jr. Chapter 11 Voluntary Asset |
|
Debtor Actient Pharmaceuticals LLC
1400 Atwater Drive Malvern, PA 19355 CHESTER-PA Tax ID / EIN: 27-2717232 |
represented by |
Paul D. Leake
Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001 212-735-3000 Fax : 212-735-2000 Email: paul.leake@skadden.com Kyle J. Ortiz
Togut, Segal & Segal LLP One Penn Plaza Suite 3335 New York, NY 10119 212-594-5000 Fax : 212-967-4258 Email: kortiz@teamtogut.com |
U.S. Trustee United States Trustee
Office of the United States Trustee U.S. Federal Office Building 201 Varick Street, Room 1006 New York, NY 10014 (212) 510-0500 |
| |
Claims and Noticing Agent Kroll Restructuring Administration LLC Claims Agent
(Formerly Prime Clerk LLC) 55 East 52nd Street 17th Floor www.kroll.com New York, NY 10055 (212) 257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 11/10/2022 | 13 | Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Actient Pharmaceuticals LLC Filed by Kyle J. Ortiz on behalf of Actient Pharmaceuticals LLC. (Ortiz, Kyle) (Entered: 11/10/2022) |
| 11/10/2022 | 12 | Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes, Summary and Schedules of Assets and Liabilities for Actient Pharmaceuticals LLC Filed by Kyle J. Ortiz on behalf of Actient Pharmaceuticals LLC. (Ortiz, Kyle) (Entered: 11/10/2022) |
| 10/27/2022 | 11 | Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: 11/10/2022 at 11:00 AM, Objections Due: 11/3/2022 at 4:00 PM) Notice of Hearing and Motion of Debtors for Entry of an Order Further Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs (Attachment: Exhibit A: Proposed Order) filed by Kyle J. Ortiz on behalf of Actient Pharmaceuticals LLC with hearing to be held on 11/10/2022 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 11/3/2022,. (Ortiz, Kyle) (Entered: 10/27/2022) |
| 10/24/2022 | 10 | Order signed on 10/24/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information. Deadline: 10/31/2022 (Related Doc # 9) (Rodriguez, Willie) (Entered: 10/24/2022) |
| 09/27/2022 | 9 | Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: October 13, 2022 at 11:00 a.m., Objection Deadline: October 6, 2022 at 4:00 p.m.) Notice of Hearing and Motion of Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs (Attachments: Exhibit A: Proposed Order) filed by Kyle J. Ortiz on behalf of Actient Pharmaceuticals LLC with hearing to be held on 10/13/2022 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 10/6/2022,. (Ortiz, Kyle) (Entered: 09/27/2022) |
| 09/12/2022 | Party Kroll Restructuring Administration LLC Claims Agent added to the case.. (Rodriguez, Willie). (Entered: 09/12/2022) | |
| 09/09/2022 | 8 | Order signed on 9/6/2022 Granting Motion Appointing Kroll Restructuring Administration LLC as Claims and Noticing Agent. (Related Doc # 6) (Rodriguez, Willie) (Entered: 09/09/2022) |
| 08/25/2022 | 7 | Order signed on 8/23/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information. Deadline: 9/29/2022 (Related Doc # 3) (Rodriguez, Willie) (Entered: 08/25/2022) |
| 08/18/2022 | 6 | Motion to Appoint Kroll Restructuring Administration LLC as Claims and Noticing Agent /Application of the Debtors for an Order (I) Appointing Kroll Restructuring Administration LLC as Claims and Noticing Agent Nunc Pro Tunc to the Petition Date; and (II) Granting Related Relief filed by Paul D. Leake on behalf of Actient Pharmaceuticals LLC. (Leake, Paul) (Entered: 08/18/2022) |
| 08/18/2022 | Case Jointly Administered with 22-22549 (Rodriguez, Willie). (Entered: 08/18/2022) |